Business Wire

AVALON-CAPITAL-PARTNERS

28.2.2020 13:48:05 CET | Business Wire | Press release

Share
Avalon Adds Five Senior Hires to Event Driven and International Equities Teams

Avalon Capital Partners Limited (“Avalon”) has hired five senior cash equity salespeople as it continues with rapid expansion plans across both Event Driven and International Equities.

In the Event Driven division, Aaron Sawyer, Holger Klees and Gregory Lafitte have joined the team to bolster Avalon’s already considerable presence in this market.

In the International Equities Division, Conor Smith and Gavin Atkins join from Cantor Fitzgerald to lead the build out of an institutional cash equity desk, providing liquidity to an international client base.

“The continued expansion of Avalon with these hires is demonstration of our commitment to the Equity space. Where others are pulling out of equities, we are expanding. There is increasing investment in European equity and we have sales, research and trading teams ready to assist our clients in maximizing their returns,” said Jean-Yves Aknin, Avalon’s CEO.

“We are delighted to add Aaron, Holger, Gregory, Conor and Gavin to Avalon. Their track record and commitment to offering the best service to institutional customers is impressive and we look forward to their contribution to our success,” added Simon Langford, Avalon’s Managing Director.

Aaron Sawyer has over 20 years’ industry experience with resultant deep-seated market and multiple economic cycle expertise. Aaron has a strong background in Equity Finance, Special Situations, ECM and Long/Short alpha strategies. Before joining Avalon, Aaron spent ten years at Credit Suisse before joining Jefferies and then Macquarie to team-up with Holger on the build out of their European operations.

Holger Klees is a specialist in Event Driven with over 20 years’ experience. Prior to joining Avalon, Holger worked for Macquarie Bank and was part of Jefferies International’s European build out. He previously worked for Pali Capital and Lehman Brothers. Holger started his career in Derivatives Sales at BHF Bank where he set up a German focused arbitrage desk.

Gregory Lafitte brings sixteen years of expertise as a portfolio manager. He has covered a variety of markets but has a focus on US and Asian special situations. Gregory started his career at CM-CIC Market where he set up and developed the Asian merger arbitrage proprietary desk. He later relocated to Europe, joining Bred Banque Populaire in 2011, where he oversaw both the US and Asian merger arbitrage proprietary trading. Since then, Gregory has held roles Opera Trading and Makor Group.

Conor Smith brings 20 years of International Equities experience with extensive knowledge of equity analysis, market making, proprietary trading and sales. He has held roles at HSBC, Man Group, MF Global and Cantor Fitzgerald.

Gavin Atkins is an industry veteran who has spent 22 years in International Equities at Cantor Fitzgerald. Prior to that, Gavin held roles at Bishop Fleming and UBS.

About Avalon Capital Partners

One of the fastest growing brokerage firms in London, Avalon is an institutional broker providing extensive market knowledge and a dedication for providing a first-class service to a global institutional client base. At Avalon, client needs are our primary focus. We guarantee an unparalleled customer service from our dedicated and experienced teams, providing access to global markets and state-of-the-art technology.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release

Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,

TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 09:31:00 CEST | Press release

Peyman Kargar appointed Director and Chief Executive Officer of TVS Motor Company, effective January 27, 2027 K. N. Radhakrishnan to continue as Director and Chief Executive Officer until then and subsequently will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027 Appointment supports TVS Motor Company's next phase of growth and innovation TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a

Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 21:27:00 CEST | Press release

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye